Status of Shares and Voting Rights of Sartorius Stedim Biotech SA

Sartorius Stedim Biotech SA, based in Aubagne, France, has communicated its total number of shares and voting rights as of March 31, 2026. This report is made in accordance with Article L 233-8-II of the French Commercial Code and Article 223-6 of the AMF General Regulation.

The company has 97,330,405 shares comprising its share capital. The total number of theoretical voting rights amounts to 164,793,507, but once treasury shares are deducted, the net number of voting rights is slightly lower, at 164,741,373.

This statement, transmitted by EQS Group, is a regular element of the financial transparency required of listed companies, providing investors and stakeholders with a clear view of Sartorius Stedim Biotech's capital structure.